BIONTECH SE's ticker is BNTX and the CUSIP is 09075V102. A total of 337 filers reported holding BIONTECH SE in Q3 2021. The put-call ratio across all filers is 1.62 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $52,009,010 | +38.2% | 478,728 | +37.3% | 0.11% | +29.3% |
| Q2 2023 | $37,626,988 | +120.6% | 348,624 | +207.1% | 0.08% | +74.5% |
| Q4 2022 | $17,054,176 | +1513.5% | 113,528 | +1348.6% | 0.05% | +1466.7% |
| Q3 2022 | $1,057,000 | +42.6% | 7,837 | +57.6% | 0.00% | +50.0% |
| Q2 2022 | $741,000 | -96.0% | 4,973 | -95.4% | 0.00% | -96.6% |
| Q1 2022 | $18,500,000 | -34.5% | 108,468 | +4.8% | 0.06% | -50.8% |
| Q3 2021 | $28,242,000 | +870.5% | 103,455 | +695.8% | 0.12% | +742.9% |
| Q2 2021 | $2,910,000 | -84.2% | 13,000 | -92.3% | 0.01% | -84.6% |
| Q1 2021 | $18,453,000 | +115.6% | 169,000 | +61.0% | 0.09% | +89.6% |
| Q4 2020 | $8,560,000 | -70.0% | 105,000 | -74.5% | 0.05% | -76.9% |
| Q3 2020 | $28,496,000 | +31.1% | 411,619 | +26.3% | 0.21% | +10.1% |
| Q2 2020 | $21,742,000 | – | 325,785 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 148,674 | $16,151,943 | 19.26% |
| Quinn Opportunity Partners LLC | 659,383 | $71,635,369 | 9.22% |
| Systrade AG | 50,000 | $5,432,000 | 4.70% |
| Crocodile Capital Partners GmbH | 29,586 | $3,214,223 | 3.03% |
| ALTRINSIC GLOBAL ADVISORS LLC | 700,421 | $76,093,737 | 2.94% |
| Temasek Holdings (Private) Ltd | 4,518,080 | $490,844,211 | 2.92% |
| PARUS FINANCE (UK) Ltd | 25,662 | $2,787,920 | 1.74% |
| FLOSSBACH VON STORCH AG | 3,513,215 | $381,675,678 | 1.68% |
| AtonRa Partners | 4,707 | $511,368 | 1.07% |
| Baader Bank Aktiengesellschaft | 135,093 | $14,617,456 | 0.99% |